Elevance Health, Inc.
ELV
$452.69
$23.365.44%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 35.67B | 35.75B | 37.01B | 36.26B | 34.02B |
| Total Other Revenue | 6.98B | 7.10B | 6.67B | 5.92B | 5.91B |
| Total Revenue | 42.65B | 42.85B | 43.67B | 42.17B | 39.93B |
| Cost of Revenue | 31.33B | 30.61B | 31.60B | 30.79B | 30.20B |
| Gross Profit | 11.31B | 12.24B | 12.07B | 11.39B | 9.74B |
| SG&A Expenses | 8.69B | 9.39B | 9.15B | 8.28B | 8.17B |
| Depreciation & Amortization | 217.00M | 212.00M | 221.00M | 235.00M | 247.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.24B | 40.21B | 40.97B | 39.30B | 38.62B |
| Operating Income | 2.40B | 2.64B | 2.70B | 2.87B | 1.32B |
| Income Before Tax | 1.00B | 1.65B | 2.44B | 2.62B | 1.05B |
| Income Tax Expenses | 170.00M | 354.00M | 585.00M | 615.00M | 168.00M |
| Earnings from Continuing Operations | 831.00M | 1.30B | 1.86B | 2.00B | 877.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.00M | -11.00M | -3.00M | -15.00M | -12.00M |
| Net Income | 856.00M | 1.29B | 1.85B | 1.99B | 865.00M |
| EBIT | 2.40B | 2.64B | 2.70B | 2.87B | 1.32B |
| EBITDA | 2.83B | 3.07B | 3.14B | 3.33B | 1.79B |
| EPS Basic | 3.63 | 5.48 | 7.83 | 8.37 | 3.59 |
| Normalized Basic EPS | 5.79 | 6.29 | 6.44 | 6.83 | 2.76 |
| EPS Diluted | 3.63 | 5.45 | 7.79 | 8.30 | 3.59 |
| Normalized Diluted EPS | 5.79 | 6.25 | 6.40 | 6.77 | 2.76 |
| Average Basic Shares Outstanding | 235.80M | 235.30M | 236.60M | 237.50M | 241.20M |
| Average Diluted Shares Outstanding | 235.80M | 236.50M | 237.80M | 239.70M | 241.20M |
| Dividend Per Share | 1.48 | 1.48 | 1.48 | 1.48 | 1.28 |
| Payout Ratio | 40.42% | 27.00% | 18.89% | 17.65% | 35.26% |
